Activities

• 

  Mary Grace N. Tamio   

  on August 08 2022 at 11:32 PM Edited public

  Nivolumab approved for combination with fluoropyrimidine- and platinum-based combination chemotherapy
  
  #nivolumab #fluoropyrimidine #chemotherapy #journals #articles
  
  For more information | ⬇️
  https://social.cn1699.cn/livenewss/news/647914/Nivolumab-approved-for-combination-with-fluoropyrimidine-and-platinum-based-combination-chemotherapy

  

  Nivolumab approved for combination with fluoropyrimidine- and platinum-based combination chemotherapy | CN1699 Social

  The social Community for Global Healthcare Elites. Doctors, Medical Professionals & Pharmaceutical professionals. Medical Thesis Abstracts and...
  0 0 0 0 0 0 0

  comment Comment

  thumb_upLike

  share Share
• 

  Mary Grace N. Tamio   

  on June 25 2022 at 07:29 PM Edited public

  Nivolumab in patients with relapsed or refractory peripheral T-cell lymphoma: modest activity and cases of hyperprogression
  
  #nivolumab #tcelllymphoma #hyperprogression #journals #articles
  
  For more information | ⬇️
  https://social.cn1699.cn/livenewss/news/608033/Nivolumab-in-patients-with-relapsed-or-refractory-peripheral-T-cell-lymphoma-modest-activity-and-cases-of-hyperprogression

  

  Nivolumab in patients with relapsed or refractory peripheral T-cell lymphoma: modest activity and cases of hyperprogression | CN1699 Social

  The social Community for Global Healthcare Elites. Doctors, Medical Professionals & Pharmaceutical professionals. Medical Thesis Abstracts and...
  0 0 0 0 0 0 0

  comment Comment

  thumb_upLike

  share Share
• 

  Mary Grace N. Tamio   

  on January 06 2022 at 03:40 PM Edited public

  Relatlimab plus nivolumab improves progression-free survival in metastatic melanoma
  
  #relatimab #nivolumab #melanoma
  
  For more information | ⬇️
  https://cn1699.com/news/relatlimab-plus-nivolumab-improves-progression-free-survival-metastatic-melanoma

  

  Relatlimab plus nivolumab improves progression-free survival in metastatic melanoma | CN1699

  In patients with untreated, advanced melanoma, the combination of immune checkpoint inhibitors relatlimab and nivolumab doubled the...
  0 0 0 0 0 0 0

  comment Comment

  thumb_upLike

  share Share
• 

  Mary Grace N. Tamio   

  on August 22 2021 at 05:54 PM Edited public

  Cemiplimab- and nivolumab-induced myasthenia gravis: two clinical cases
  
  #cemiplimab #nivolumab #myastheniagravis #journals #articles
  
  For more information |⬇️
  https://social.cn1699.cn/livenewss/news/272430/Cemiplimab-and-nivolumab-induced-myasthenia-gravis-two-clinical-cases

  

  Cemiplimab- and nivolumab-induced myasthenia gravis: two clinical cases | CN1699 Social

  The social Community for Global Healthcare Elites. Doctors, Medical Professionals & Pharmaceutical professionals. Medical Thesis Abstracts and...
  0 0 0 0 0 0 0

  comment Comment

  thumb_upLike

  share Share